The Short Answer
Patients research this comparison from both directions, LASIK vs ICL or ICL vs LASIK, and the honest answer is the same either way: the right procedure depends on your prescription, your corneal anatomy, and your long-term plans for your vision. This guide walks through how I make that call with each patient.
For most patients with a healthy, adequately thick cornea and a prescription within range, LASIK is an excellent and more economical choice. For patients with high myopia, thin corneas, dry eye risk, or a desire to keep every future lens option open, EVO ICL™ is frequently the better procedure, because it corrects vision without removing any corneal tissue and can be removed if your needs ever change.
I am Dr. Gregg Feinerman, and I have performed both LASIK and EVO ICL in Newport Beach for more than two decades. I was among the first surgeons in California to implant the Implantable Collamer Lens after its FDA approval in 2005, and I have implanted this technology, now in its advanced EVO form, ever since. I was also the first surgeon in Orange County and greater Los Angeles to perform WaveLight® Plus LASIK following its FDA approval. I offer both procedures because neither one is right for every eye. The honest answer to which is better is that it depends on the eye in front of me. This page explains how I think through that decision.
How Each Procedure Works
LASIK Reshapes the Cornea
LASIK (Laser-Assisted In Situ Keratomileusis) corrects vision by reshaping the cornea, the clear front surface of the eye. I create a thin corneal flap with a femtosecond laser, an excimer laser removes a precise amount of tissue to change the corneal curvature, and the flap is repositioned. For the right candidate, LASIK is fast, comfortable, and produces outstanding results. The most advanced LASIK platform available in the United States, WaveLight® Plus with INNOVEYES SightMap™, uses ray-tracing to model the full optical system of the eye, and it is the platform I use for my most customized cases.
The key point to understand is that LASIK is subtractive and permanent. It works by removing corneal tissue, and tissue that has been removed cannot be replaced.
EVO ICL Adds a Lens and Removes Nothing
EVO ICL stands for EVO Implantable Collamer Lens. It is an advanced phakic intraocular lens, FDA-approved for adults ages 21 to 60, that corrects moderate to high myopia and myopic astigmatism. Rather than reshaping the cornea, I place a micro-thin, biocompatible lens inside the eye, just behind the iris and in front of the natural lens. Nothing is removed. The cornea is preserved, the natural lens is preserved, and the eye keeps its own ability to focus.
EVO ICL is additive, not subtractive. That single distinction drives almost every advantage that follows.
Why EVO ICL Is the Better LASIK Alternative for High Prescriptions
Clinical Data
EVO ICL treats nearsightedness from -3.00 to -20.00 diopters, with or without astigmatism. LASIK becomes less reliable and eventually unsafe at higher prescriptions, because correcting a strong prescription requires removing more corneal tissue than many corneas can safely spare.
LASIK corrects a prescription by removing corneal tissue, and the higher the prescription, the more tissue must be removed. Past a certain point, removing enough tissue either produces unreliable results, such as regression of the correction, poor night vision, or glare and halos, or it compromises the structural integrity of the cornea. Patients with high myopia are frequently turned away from LASIK for exactly this reason.
EVO ICL does not depend on corneal tissue at all. Because it adds a corrective lens rather than subtracting tissue, it delivers sharp, stable vision across a far broader range of prescriptions, including prescriptions that LASIK cannot safely reach. For patients with long eyes (an axial length above 26 millimeters), EVO ICL is often the safest first option. Long, highly myopic eyes carry an elevated lifetime risk of retinal detachment, so preserving the natural lens, as EVO ICL does, is a meaningful advantage for these patients in their 20s, 30s, 40s, and 50s.
For a deeper look at the tissue and night vision limits behind the LASIK ceiling, including the percent tissue altered calculation, see our dedicated resource on EVO ICL for high prescriptions.
Why EVO ICL Is the Better LASIK Alternative for Thin Corneas
Some patients have corneas that are perfectly healthy but naturally thinner than average. LASIK requires a minimum corneal thickness to preserve the eye’s long-term structural integrity, because the procedure works by removing tissue from that cornea. Removing tissue from an already-thin cornea raises the risk of post-surgical instability and disappointing optical quality.
Because EVO ICL preserves 100 percent of the cornea, corneal thickness is simply not a limiting factor. Many patients who have been told elsewhere that they are not LASIK candidates because of thin corneas are excellent candidates for EVO ICL. If you have been turned down for LASIK, this is one of the first things I want to evaluate.
For a deeper look at how thin corneas affect candidacy and why EVO ICL is so often the right answer for this group of patients, see our dedicated resource on thin corneas and vision correction.
Why EVO ICL Is a Better Choice for Patients With Dry Eye
Patient Outcomes
Because EVO ICL does not require a corneal flap, it does not disrupt the corneal nerves that regulate tear production the way LASIK can. For patients with existing dry eye or meaningful dry eye risk factors, post-operative dryness is significantly less common with EVO ICL than with LASIK, and the ocular surface typically recovers more quickly.
Dry eye is one of the most common concerns I hear from patients considering vision correction, and it is one of the most important factors I assess before recommending a procedure. The concern is well founded when it comes to LASIK.
Creating a LASIK flap requires severing a portion of the corneal nerves responsible for tear production and ocular surface sensation. Those nerves regenerate over time, and most patients recover well. But patients who already tend toward dry eye, whose hormonal status predisposes them to it, whose work or environment involves prolonged screen time, low humidity, or air conditioning, or whose baseline tear film is borderline can experience meaningful and sometimes prolonged dryness after LASIK. For this group, the procedure can turn a manageable condition into a significant quality-of-life issue.
EVO ICL is performed through a tiny, self-sealing incision at the peripheral edge of the cornea. That incision does not cross the central or mid-peripheral cornea, which is where the tear-regulating nerve density is highest. As a result, the nerves that signal the eye to produce tears are not disrupted in the same way, and post-operative dry eye is significantly less common.
If you have ever used prescription drops for dry eye, have noticed consistent end-of-day dryness, or have been told your tear film is thin, this difference is worth weighing carefully. In my evaluation, I assess your tear film quality, your Schirmer score, and your corneal surface before making a recommendation. For patients with meaningful dry eye risk, EVO ICL is frequently the more comfortable long-term choice. I go deeper on this topic, including long-term tear-film data, on my page about EVO ICL for dry eye.
The track record behind the lens is substantial. More than 4 million implantable collamer lenses have been sold worldwide, and among patients studied, the implantable collamer lens carries a 99.4% satisfaction rate.
The Reversible Vision Correction Advantage: A Benefit Measured in Decades
You can see this advantage in motion on my interactive 3D tour of the EVO ICL™, which shows where the lens sits and how it can be removed through a small incision at the limbus.
Practice Differentiator
EVO ICL is reversible. The lens can be removed or exchanged by a qualified surgeon if your needs change. LASIK is permanent. This difference becomes unexpectedly important decades later, when every patient eventually develops presbyopia and dysfunctional lens syndrome and faces a lens-based procedure. The procedure you choose today quietly shapes which lens technologies will be available to you then. For the long-view version of this argument, see EVO ICL and the choices you keep.
This is the advantage I find patients understand the least at the time of their decision, and appreciate the most years later. Every patient, regardless of refractive history, eventually develops presbyopia, the age-related loss of near focus that begins in the mid-40s. Over the following years the natural lens continues to stiffen, yellow, and lose clarity, a progression now recognized as dysfunctional lens syndrome. That progression ultimately becomes a cataract, at which point the natural lens must be replaced with an intraocular lens.
Why Prior LASIK Limits Future Lens Options
Modern cataract and refractive lens exchange surgery offers a meaningful menu of intraocular lenses, each suited to different visual priorities and lifestyles. At Feinerman Vision, I implant the enVista family for patients who want a reliable, high-quality monofocal result; Clareon® Vivity® for patients seeking extended depth of focus with excellent distance and intermediate vision and minimal visual disturbances at night; Clareon® PanOptix® Pro for patients who prioritize a full range of vision, including near, with reduced glasses dependence; FINEVISION HP as a trifocal option in the premium presbyopia-correcting category; the Apthera IOL for patients with irregular corneas, including those who have had prior refractive surgery such as radial keratotomy; and the Light Adjustable Lens for patients who want to fine-tune their refractive outcome after surgery.
Prior LASIK changes this calculus significantly. Because LASIK permanently alters the corneal curvature, calculating the correct intraocular lens power becomes less predictable. The optical changes introduced by LASIK also reduce the visual quality patients can achieve from advanced multifocal and trifocal lenses, which depend on a smooth, predictable corneal surface to perform well. In practice, patients who have had LASIK are generally limited to a standard monofocal lens or the Light Adjustable Lens, which earns its place in this group precisely because its power can be adjusted after surgery to compensate for the reduced predictability of post-LASIK lens calculations. The premium trifocal lenses that deliver the highest rates of complete glasses independence are typically not the right match for a post-LASIK eye, and placing them risks disappointment.
Why Prior EVO ICL Preserves Every Future Option
Patients who chose EVO ICL earlier in life are in a fundamentally different position. When presbyopia, dysfunctional lens syndrome, or cataract eventually calls for lens-based surgery, the EVO ICL is simply removed. The cornea is entirely untouched. Lens-power calculations are as accurate as they would be in any eye that never had surgery. And the patient keeps access to the full menu of lens technologies: enVista, Clareon® Vivity®, Clareon® PanOptix® Pro, FINEVISION HP, the Apthera IOL, the Light Adjustable Lens, and any lens that does not yet exist.
That last point matters more than most patients realize. Lens design and refractive surgery continue to advance quickly. An untouched cornea is the best possible platform for whatever technology emerges over the next two or three decades. Choosing EVO ICL today is, in a real sense, a decision that protects your options tomorrow.
EVO ICL vs. LASIK: Side-by-Side Comparison
| Feature | LASIK | EVO ICL |
|---|---|---|
| FDA-approved age range | Generally 18 and older | Ages 21 to 60 |
| How it works | Removes corneal tissue | Adds a lens behind the iris |
| High prescriptions | Limited at higher myopia | Up to -20.00 diopters |
| Thin corneas | Minimum thickness required | No thickness requirement |
| Dry eye impact | Flap disrupts corneal nerves; elevated risk in susceptible patients | No flap; minimal nerve disruption; significantly lower dry eye risk |
| Reversibility | Permanent | Reversible |
| Future lens options | Usually monofocal or Light Adjustable Lens only | Full premium lens menu preserved |
| Future technology access | Limited by altered corneal shape | Untouched cornea; candidate for any future technology |
| Native accommodation | Preserved | Preserved |
| UV protection | None built in | Built into the lens material |
Both procedures preserve the eye’s natural accommodation, and both offer fast visual recovery, typically within hours to a day.
LASIK vs ICL: What Each Costs in Orange County
Cost is part of this decision, so here are our current figures. LASIK at Feinerman Vision starts at $4,100 for both eyes, and WaveLight® Plus LASIK is $5,100. EVO ICL is $9,450 all inclusive. All figures are subject to change, and advertised prices elsewhere often exclude pre-operative testing, enhancements, and follow-up care, so ask what is included. For full breakdowns, see our guides to EVO ICL cost in Orange County and LASIK cost.
On timing: LASIK takes about 15 minutes for both eyes, with the laser active only seconds per eye. EVO ICL takes 10 to 15 minutes per eye. Both are outpatient procedures with fast visual recovery.
When LASIK Is Still the Right Choice
I want to be clear that LASIK remains an outstanding procedure, and I perform it often. For a patient in their 20s or 30s with a stable prescription, a healthy cornea of adequate thickness, a clear natural lens, and no significant dry eye risk, LASIK is faster and less invasive, and it is the first conversation I have. WaveLight® Plus with INNOVEYES SightMap™ brings a level of optical customization earlier laser platforms could not match. EVO ICL is not universally better. It is better for specific eyes, and matching the procedure to the eye is the entire point of a thorough evaluation.
That said, the balance is shifting across the country. US laser vision correction volume fell 52 percent from 2022 to 2026 while EVO ICL adoption rose 76 percent; I explain the reasons in why vision correction is shifting from laser to lens.
How I Decide With Each Patient in Orange County
- I review your prescription, including whether it falls within the safe LASIK range or into the higher myopia where EVO ICL is stronger.
- I measure corneal thickness and overall corneal health on advanced imaging.
- I assess your tear film quality, your dry eye risk factors, and your ocular surface health, because this affects both candidacy and long-term comfort.
- I evaluate axial length and retinal health, which matter most in long, highly myopic eyes.
- I talk with you about your age and your long-term plan, including the lens options you want to preserve for the decades ahead.
If you would like to learn what each procedure looks like in practice, you can read more about what to expect during the EVO ICL procedure and recovery, or return to the EVO ICL overview. For a full breakdown of who qualifies for EVO ICL and who does not, see my EVO candidate guide. Try our Candidacy Quiz to help consider which vision correction procedure is best for you.
Book Your EVO ICL Consultation in Newport Beach
The only way to know which procedure is right for your eyes is a comprehensive evaluation. I conduct every consultation personally. To schedule, call (949) 631-4780 or request a personalized consultation at FeinermanVision.com.
EVO ICL™ in Orange County and the Los Angeles Area
Feinerman Vision is a boutique, single-surgeon practice based in Newport Beach. Dr. Feinerman personally handles every consultation and performs every EVO ICL procedure himself, and patients come to the Newport Beach office from throughout Orange County and greater Los Angeles, including Irvine, Costa Mesa, Huntington Beach, and Long Beach. If you are weighing EVO ICL against LASIK and want an honest, in-person assessment of which one fits your eyes, you can learn more about EVO ICL in Orange County and then book a visit.
Because the care comes from the surgeon rather than a rotating team, Dr. Feinerman calls each patient the evening of surgery and sees them himself the next day, with no hand-offs to outside providers. Schedule your consultation with Dr. Feinerman to review your candidacy, your prescription, and your long-term lens options.
Frequently Asked Questions: EVO ICL vs. LASIK
LASIK vs. ICL: Which Is Better for My Eyes?
For many patients, the EVO ICL™ is the better option, particularly with a high prescription, thin corneas, or dry eye risk, because it removes no corneal tissue and is reversible. LASIK reshapes the cornea and is an excellent option for patients with a stable prescription and a healthy, adequately thick cornea. There is no single answer that fits everyone: the better procedure depends on your anatomy, prescription, and long-term visual goals, which is what Dr. Feinerman evaluates during your consultation.
Is EVO ICL Better Than LASIK?
Neither procedure is universally better. EVO ICL is often the better choice for high prescriptions, thin corneas, dry eye risk, and patients who want to preserve every future lens option, because it removes no corneal tissue and is reversible. LASIK is an excellent choice for patients with a healthy, adequately thick cornea and a prescription within its safe range.
Can EVO ICL Correct a Prescription That Is Too Strong for LASIK?
Often, yes. EVO ICL is FDA-approved to treat nearsightedness from -3.00 to -20.00 diopters. Many patients who exceed the safe LASIK range are excellent EVO ICL candidates.
Is EVO ICL Reversible While LASIK Is Not?
Correct. The EVO ICL can be removed or exchanged by a surgeon if your needs ever change. LASIK permanently removes corneal tissue, which cannot be replaced.
Why Does Reversibility Matter If I Am Young?
Because every eye eventually develops presbyopia and dysfunctional lens syndrome and will need a lens-based procedure later in life. Patients who have had LASIK are generally limited to a standard monofocal or the Light Adjustable Lens at that point. Patients who have had EVO ICL can have the lens removed and keep access to the full range of premium lenses, including extended depth-of-focus and trifocal lenses such as Clareon® Vivity® and Clareon® PanOptix® Pro, plus any lens technology developed in the future.
Is EVO ICL Better for Dry Eyes?
For patients with dry eye risk factors, generally yes. EVO ICL does not require a corneal flap, so it does not disrupt the tear-regulating corneal nerves the way LASIK does. Post-operative dry eye is significantly less common, and patients with a history of dry eye, borderline tear film, or prolonged screen use should weigh this difference carefully.
What If I Have Thin Corneas?
Thin corneas can disqualify a patient from LASIK, but they are not a barrier to EVO ICL, which adds a lens without removing any corneal tissue. Many of my best EVO ICL candidates are patients who were told they could not have LASIK because of thin corneas.